Global Clinical Nutrition For Diabetes Care Market Size and Forecast 2024-2033

Overview and Scope
Clinical nutrition for diabetes care refers to offering specialized dietary guidance and nutritional support to individuals managing diabetes. It encompasses personalized assessments, meal planning, and education on carbohydrate management, glycemic control, and lifestyle modifications. The primary aim is to optimize nutrition, regulate blood sugar levels, prevent complications, and enhance overall health outcomes for those with diabetes.

Sizing and Forecast
The clinical nutrition for diabetes care market size has grown strongly in recent years. It will grow from $2.72 billion in 2023 to $2.93 billion in 2024 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to medical professional advocacy, rise in lifestyle diseases, increased awareness among consumers, healthcare infrastructure development, and rising diabetes prevalence.

The clinical nutrition for diabetes care market size is expected to see strong growth in the next few years. It will grow to $4 billion in 2028 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to insurance coverage for diabetes management, healthcare expenditure, obesity epidemic, aging population, and rising diabetes prevalence. Major trends in the forecast period include increasing focus on immune-supportive nutrition, plant-based nutrition, functional foods and supplements, digital health integration, and personalized nutrition plans.

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/clinical-nutrition-for-diabetes-care-global-market-report

Segmentation & Regional Insights
The clinical nutrition for diabetes care market covered in this report is segmented –
1) By Product: Oral Nutrition, Parenteral Nutrition, Enteral Feeding Formulas
2) By Stage: Adult, Pediatric
3) By Sales Channel: Online, Retail, Institutional Sales

North America was the largest region in the clinical nutrition for diabetes care market in 2023. The regions covered in the clinical nutrition for diabetes care market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15540&type=smp

Major Driver Impacting Market Growth
The increase in the prevalence of diabetes is expected to propel the growth of the clinical nutrition for diabetes care market going forward. Diabetes is a group of metabolic disorders characterized by high blood sugar levels over a prolonged period, resulting from either inadequate insulin production or the body's ineffective use of insulin. The prevalence of diabetes is driven by factors such as sedentary lifestyles, unhealthy diets, genetic predisposition, and aging populations. Clinical nutrition for diabetes care is crucial in helping diabetes patients to manage their condition by providing tailored dietary plans that regulate blood sugar levels, promote weight management, and reduce the risk of complications. For instance, according to the International Diabetes Federation, a Belgium-based umbrella organization, there were 537 million people aged 20-79 years with diabetes in 2021, a number projected to rise to 643 million by 2030 and 783 million by 2045. Therefore, the increase in the prevalence of diabetes is driving the growth of the clinical nutrition for diabetes care market.

Key Industry Players
Major companies operating in the clinical nutrition for diabetes care market are Pfizer Inc., Bayer AG, Sanofi-Aventis LLC, Abbott Laboratories, Roche Holdings Inc, Medtronic plc, Danone SA, Eli Lilly and Company, Amgen Inc., Senseonics Holdings Inc., Teva Pharmaceutical Industries Ltd, Baxter International Inc., B. Braun Melsungen AG, Glanbia plc, Perrigo Company plc, Dexcom Inc., Nestlé Health Science S.A., Tandem Diabetes Care, Nutricia International Private Limited, MannKind Corp, Omada Health, Senseonics Holdings Inc., Diasome Pharmaceuticals Inc., Zucara Therapeutics Inc, Victus Inc.

The clinical nutrition for diabetes care market report table of contents includes:
1. Executive Summary
2. Clinical Nutrition For Diabetes Care Market Characteristics
3. Clinical Nutrition For Diabetes Care Market Trends And Strategies
4. Clinical Nutrition For Diabetes Care Market - Macro Economic Scenario
5. Global Clinical Nutrition For Diabetes Care Market Size and Growth

....

32. Global Clinical Nutrition For Diabetes Care Market Competitive Benchmarking
33. Global Clinical Nutrition For Diabetes Care Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Clinical Nutrition For Diabetes Care Market
35. Clinical Nutrition For Diabetes Care Market Future Outlook and Potential Analysis
36. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model